ALLODD
  • Home
    • ALLODD Overview
    • Governing Bodies
  • People
    • Beneficiaries
    • Partner Organisations
    • Supervisors
    • Early Stage Researchers
  • Research
    • Work Packages
    • Individual Research Projects
  • Training
    • Training Events >
      • 1st Workshop and PhD Induction Course
      • 1st Training School & Networking Meeting
      • Allostery in Drug Discovery Awareness Event and Symposium
    • Secondments
    • ALLODD Webinars
    • Courses & Lectures
    • Journal Club
  • Dissemination
    • Publications
    • Events
    • Communication Material
    • Social Media
    • Newsletter
  • Events
    • ALLODD Events
    • ALLODD Webinars
    • Courses & Lectures
    • Satellite Events
  • Newsroom
  • Job Openings
  • Blog
  • Contact

ESR8: Nina-Louisa Efrém

Picture
Vertical Divider
Host Organization
Nazaré Lab
 Leibniz Research Institute for Molecular Pharmacology (FMP)
Berlin, Germany

Supervisor
Dr. Marc Nazaré
Picture
Design and synthesis of allosteric phosphatase inhibitors
The cytosolic protein tyrosine phosphatase SHP2 plays a central role in oncogenic signaling cascades and therefore attracts considerable attention as a therapeutic target for the treatment of cancer. However, the development of drug-like inhibitors for the SHP2 catalytic site has proven challenging due to its highly conserved and positively charged character, decreasing the selectivity and bioavailability of active-site inhibitors. An alternative strategy to target SHP2 is the development of negative allosteric modulators that lock the protein in its autoinhibited conformation. Emerging allosteric SHP2 inhibitors show favorable pharmacokinetic properties compared to active-site inhibitors and have recently entered clinical trials.
My project focuses on the development of novel allosteric chemical probes that can provide a better understanding of the molecular pharmacology of SHP2 inhibition and its implications in (patho-)physiology.

Brief Scientific Bio
I obtained my Bachelor’s degree from Freie Universität Berlin, Germany, in 2018. Originally having a background in Biochemistry, I discovered my passion for Medicinal Chemistry and Organic Synthesis early on during my studies. In line with this interest, I carried out internships at Bayer Pharmaceuticals and at the Max Planck Institute of Colloids and Interfaces before moving to the Netherlands for my Master’s in Drug Design and Synthesis at Vrije Universiteit Amsterdam. After my graduation in 2020, I did a gap year in industry, participating in the Roche internship in Medicinal Chemistry (RiCH) program in Basel, Switzerland. Returning to Berlin for my PhD, I joined the group of Dr. Marc Nazaré at the Leibniz Institute for Molecular Pharmacology and am now mainly working on the development of allosteric phosphatase modulators.
Picture
Picture
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956314.
Disclaimer | Privacy Policy
Powered by Create your own unique website with customizable templates.
  • Home
    • ALLODD Overview
    • Governing Bodies
  • People
    • Beneficiaries
    • Partner Organisations
    • Supervisors
    • Early Stage Researchers
  • Research
    • Work Packages
    • Individual Research Projects
  • Training
    • Training Events >
      • 1st Workshop and PhD Induction Course
      • 1st Training School & Networking Meeting
      • Allostery in Drug Discovery Awareness Event and Symposium
    • Secondments
    • ALLODD Webinars
    • Courses & Lectures
    • Journal Club
  • Dissemination
    • Publications
    • Events
    • Communication Material
    • Social Media
    • Newsletter
  • Events
    • ALLODD Events
    • ALLODD Webinars
    • Courses & Lectures
    • Satellite Events
  • Newsroom
  • Job Openings
  • Blog
  • Contact